The public record · 119th Congress

Affordable Pricing for Taxpayer-Funded Prescription Drugs Act of 2026

The Congressional Research Service has not published a summary of this measure.

Other titles

the names this measure carries besides the one at the top of this page, each with the record's own label for it. The collection includes titles given to parts of a bill as well as to the whole.

To require persons who undertake federally funded research and development of a biomedical product or service to enter into reasonable pricing agreements with the Secretary of Health and Human Services, and for other purposes.Official Title as Introduced

Affordable Pricing for Taxpayer-Funded Prescription Drugs Act of 2026Short Title(s) as Introduced

Legislative history

H.R. 10094·House·Bill·Health

Rep. Val T. Hoyle(Democratic-Oregon-4)·

Aug 13, 2026

IntroducedIntroduced in House

Aug 13, 2026

HouseReferred to the House Committee on Energy and Commerce.

Documents

Everything Congress printed about this measure. A bill is reprinted each time it changes, the Congressional Research Service summarizes each version, and the committee that reports a bill files its own written account of it.

Bill text

Aug 13, 2026As introduced in the House